The Effects of SGLT2 Inhibitors on Lipid Metabolism

Sodium glucose co-transporter 2 (SGLT2) inhibitors are effective antihyperglycemic agents by inhibiting glucose reabsorption in the proximal tubule of the kidney. Besides improving glycemic control in patients with type 2 diabetes, they also have additional favorable effects, such as lowering body w...

Descripción completa

Detalles Bibliográficos
Autores principales: Szekeres, Zsolt, Toth, Kalman, Szabados, Eszter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912792/
https://www.ncbi.nlm.nih.gov/pubmed/33535652
http://dx.doi.org/10.3390/metabo11020087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912792/
https://www.ncbi.nlm.nih.gov/pubmed/33535652
http://dx.doi.org/10.3390/metabo11020087

Ejemplares similares